APOE and breast carcinoma: Impact of APOE ε2 genotype on adjusted longitudinal scores on objective cognition test domains and FACT-Cog Perceived Cognitive Impairment Scores among older breast cancer survivors (n = 412) and noncancer controls (n = 407) excluding ε2/4 genotypea,b